Twice‐daily compared with oncedaily thoracic radiotherapy in limited smal‐cel lung cancer treated concurrently with cisplatin and etoposide .Phase I studies of imatinib mesylate combined with cisplatin andirinotecanin patients with smal cel lung carcinoma ......